From the Journals

Transoral robotic surgery assessed for oral lesions

Publish date: September 29, 2017
By
M. Alexander Otto

 


A single-arm study is being conducted at the Ohio State University Comprehensive Cancer Center, Columbus, to assess transoral robotic surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the da Vinci Robotic Surgical System.

The study started in 2007, and the estimated completion date is December 2020. Investigators hope to enroll 360 adults.

The goal is to determine the feasibility of TORS in patients with benign and malignant lesions; the impact of TORS on operative time, blood loss, and complications; and the quality of life of TORS patients out to 8 years. The investigators are also measuring the efficiency and accuracy of surgeons who perform the procedure to quantify the learning curve.

Patients are scheduled for regular postop visits to assess quality of life and other matters. Those unable to return to Ohio State University are contacted by phone or provided with the questionnaire by mail.

Recommended Reading

Robot-assisted surgery can be a pain
MDedge Surgery
Confirmatory blood typing unnecessary for closed prolapse repairs
MDedge Surgery
Predicting extraction of an intact uterus in robotic-assisted laparoscopic hysterectomy
MDedge Surgery
Robotic-assisted IHR causes fewer complications in obese patients
MDedge Surgery
Clinical trial: Use of robotics for cholecystectomy
MDedge Surgery
Clinical trial: Sinai Robotic Surgery Trial in HPVOPC
MDedge Surgery
Adoption of robotic-assisted surgery uneven across specialties
MDedge Surgery
Peer-to-peer learning about robotic surgery is happening on social media
MDedge Surgery
Robot-assisted prostatectomy providing better outcomes
MDedge Surgery
Robotic surgery technologies have unique learning curves for trainees
MDedge Surgery